| abstract |
The present invention relates to advantageous and novel delivery devices for cetyl myristoleate compositions. Supply devices include transdermal delivery devices, suppositories, intranasal delivery devices, enteric coatings and micro-encapsulation. In turn, methods are also provided to treat pain and disease using the delivery devices described. Diseases can also be treated with devices that include, but are not limited to, diseases associated with pain or inflammation of the tissues, diseases associated with pain or inflammatory conditions that affect joints, autoimmune diseases and allergies. |